Oncotarget

Research Papers:

Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression

Chung-Yu Chen, Ying-Yin Chen, Jeremy J.W. Chen, Kuan-Yu Chen, Chao-Chi Ho, Jin-Yuan Shih, Yih-Leong Chang _, Chong-Jen Yu and Pan-Chyr Yang

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:61901-61916. https://doi.org/10.18632/oncotarget.18717

Metrics: PDF 513 views  |   HTML 1187 views  |   ?  


Abstract

Chung-Yu Chen1,2,3, Ying-Yin Chen1, Jeremy J.W. Chen4, Kuan-Yu Chen2, Chao-Chi Ho2, Jin-Yuan Shih2,*, Yih-Leong Chang3,*, Chong-Jen Yu2 and Pan-Chyr Yang2

1Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Douliu, Taiwan

2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan

3Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan

4Institute of Biomedical Science, College of Life Sciences, National Chung Hsing University, Taichung, Taiwan

*These authors have contributed equally to this work

Correspondence to:

Yih-Leong Chang, email: ntuhylc@gmail.com

Jin-Yuan Shih, email: jyshih@ntu.edu.tw

Keywords: lung cancer, pemetrexed, thymidylate synthase, astrocyte elevated gene-1, chemoresistance

Received: March 29, 2017     Accepted: May 03, 2017     Published: June 28, 2017

ABSTRACT

Previous studies have suggested that astrocyte-elevated gene-1 (AEG-1) contributes to the mechanisms of resistance to various chemotherapeutics. In this study, we investigated whether AEG-1 expression level correlated with that of thymidylate synthase (TS), as higher TS expression is known to be associated with the resistance to pemetrexed chemotherapy in patients with advanced lung adenocarcinoma. Using pemetrexed-resistant lung adenocarcinoma PC-9 cell line, we demonstrated that transfection of AEG-1 siRNA lowered TS expression and decreased pemetrexed IC50 value. In contrast, overexpression of AEG-1 was associated with increased expression of TS and higher pemetrexed IC50 value. Immunohistochemical staining of clinical biopsy samples showed that patients with lower AEG-1 expression had longer overall survival time. Moreover, analysis of repeated biopsy samples revealed that an increase in the TS level from baseline to disease progression was significantly associated with the elevation of AEG-1 expression. In conclusion, our data demonstrated that TS expression might be regulated by AEG-1 and that increased expression of these proteins contributes to lung cancer disease progression and may be associated with the development of resistance to pemetrexed.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18717